Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

62.63
+1.332.17%
Pre-market: 60.80-1.8300-2.92%04:45 EDT
Volume:7.89M
Turnover:492.25M
Market Cap:278.02B
PE:19.94
High:62.74
Open:62.48
Low:61.84
Close:61.30
Loading ...

Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes

TipRanks
·
11 Mar

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Zacks
·
11 Mar

Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial

Benzinga
·
11 Mar

Ozempic's New Frontier: The War on Aging -- WSJ

Dow Jones
·
11 Mar

Post-Bell|Nasdaq Falls 4%; Tesla Falls 15%; Nvidia, Apple Drop 5%; Coinbase Plunges 18%; Palantir Tumbles 10%; Redfin Soars 68%

Tiger Newspress
·
11 Mar

Health Care Down as Novo Nordisk Plunges -- Health Care Roundup

Dow Jones
·
11 Mar

Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations

TIPRANKS
·
11 Mar

Eli Lilly's first weight-loss pill could expand access to GLP-1s around the globe, executive says

Quartz
·
11 Mar

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires Live
·
11 Mar

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
11 Mar

Why Novo Nordisk Stock Is Falling Today

Motley Fool
·
10 Mar

Novo Nordisk under pressure as obesity drug disappoints in diabetes trial

TIPRANKS
·
10 Mar

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
10 Mar

Novo Nordisk stock slides Monday on second-generation GLP-1 data

Yahoo Finance
·
10 Mar

Novo Nordisk (0QIU) Gets a Hold from Bernstein

TIPRANKS
·
10 Mar

Cautious Hold Rating on Novo Nordisk Amid Comparable Trial Results and Market Uncertainties

TIPRANKS
·
10 Mar

H.C. Wainwright says Novo results support Viking obesity potential

TIPRANKS
·
10 Mar

Morgan Stanley sees ‘limited impact’ to Lilly shares from Novo CagriSema data

TIPRANKS
·
10 Mar

Novo Nordisk Says Trial With Next-Gen Drug In Diabetics Shows 15.7% Weight Loss

Reuters
·
10 Mar

Hikma looks to launch generic versions of Novo Nordisk diabetes drugs, FT says

TIPRANKS
·
10 Mar